Literature DB >> 24370283

Laparoscopic partial nephrectomy for endophytic hilar tumors: feasibility and outcomes.

G B Di Pierro1, N Tartaglia2, L Aresu3, A Polara3, A Cielo3, C Cristini2, P Grande2, V Gentile2, G Grosso3.   

Abstract

OBJECTIVE: To analyze feasibility and outcomes of laparoscopic partial nephrectomy (LPN) for endophytic hilar tumors in low-intermediate (ASA I-II) risk patients.
METHODS: This is a single centre retrospective study. From May 2009 to September 2011, 208 LPNs were performed at our institution. Overall 11 (5.2%) elective LPNs were for hilar tumors not visible on kidney surface. Hilar tumor was defined as a mass located in the renal hilum and in contact with a major renal vessel on preoperative imaging. Procedures were carried out by a single experienced surgeon (G.G.) via retroperitoneal approach by clamping the only main renal artery.
RESULTS: Mean (range) age of patients was 45.3 years (38.2-64.1), tumor size 1.6 cm (1.2-2.0), warm ischemia time 24 min (19-32), operative time 140 min (110-200) and estimated blood loss 270 ml (100-750). Two collecting system injuries were observed and repaired intraoperatively. No conversion to open surgery was required. Final pathological examination revealed 10 renal cell carcinomas and 1 oncocytoma. A negative surgical margin was obtained in 10/11 (91%) patients. Renal function and serum hemoglobin were nearly unaltered pre and post-surgery. No tumor recurrence was observed at mean (range) follow-up of 34 months (15-43).
CONCLUSIONS: In experienced hands, LPN represents a feasible, safe and effective treatment for selected patients diagnosed with endophytic hilar masses. A larger number of patients and longer follow-up are required to draw definitive conclusions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complications; Endophytic hilar tumors; Laparoscopic partial nephrectomy; Renal function; Tumor recurrence

Mesh:

Year:  2013        PMID: 24370283     DOI: 10.1016/j.ejso.2013.11.023

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Robust augmented reality registration method for localization of solid organs' tumors using CT-derived virtual biomechanical model and fluorescent fiducials.

Authors:  Seong-Ho Kong; Nazim Haouchine; Renato Soares; Andrey Klymchenko; Bohdan Andreiuk; Bruno Marques; Galyna Shabat; Thierry Piechaud; Michele Diana; Stéphane Cotin; Jacques Marescaux
Journal:  Surg Endosc       Date:  2016-10-27       Impact factor: 4.584

Review 2.  Robot-assisted Partial Nephrectomy for Endophytic Tumors.

Authors:  Dae Keun Kim; Christos Komninos; Lawrence Kim; Koon Ho Rha
Journal:  Curr Urol Rep       Date:  2015-11       Impact factor: 3.092

3.  Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches.

Authors:  Hideaki Miyake; Nobuyuki Hinata; Satoshi Imai; Junya Furukawa; Kazushi Tanaka; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2015-01-23       Impact factor: 3.402

4.  A Modified Two-Layer Suture Technique for Transperitoneal Laparoscopic Partial Nephrectomy: Single-Center Clinical Experience.

Authors:  Yang Jin; Hui Xiong; Qinghua Xia; Qi Zhang
Journal:  Front Surg       Date:  2022-02-01

5.  Partial Nephrectomy Versus Radical Nephrectomy for Endophytic Renal Tumors: Comparison of Operative, Functional, and Oncological Outcomes by Propensity Score Matching Analysis.

Authors:  Situ Xiong; Ming Jiang; Yi Jiang; Bing Hu; Ru Chen; Zhijun Yao; Wen Deng; Xianwen Wan; Xiaoqiang Liu; Luyao Chen; Bin Fu
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

6.  Modified Laparoscopic Nephron-Sparing Surgery for Large Renal Hilar Angiomyolipoma: Dual-Center Experience.

Authors:  ZeSong Yang; Fang Wang; Deng Lin; Qiuyan Li; Yun Hong; Minxiong Hu; Dahong Zhang; Liefu Ye
Journal:  Front Surg       Date:  2022-06-08

7.  Robot-assisted versus laparoscopic partial nephrectomy for anatomically complex T1b renal tumors with a RENAL nephrometry score ≥7: A propensity score-based analysis.

Authors:  Wen Deng; Junhua Li; Xiaoqiang Liu; Luyao Chen; Weipeng Liu; Xiaochen Zhou; Jingyu Zhu; Bin Fu; Gongxian Wang
Journal:  Cancer Med       Date:  2019-12-02       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.